News | May 29, 2022
JBCL rebrands as JB
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
The facility is spread across 215000 sq. feet and provides super-speciality care
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
It will be marketed under the brand name Molunamax
The capsules are the generic version of the reference listed drug Mycobutin
Subscribe To Our Newsletter & Stay Updated
